Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)

SHA:688298 Revenue

In the year 2025, Zhejiang Orient Gene Biotech had annual revenue of 958.99M CNY with 15.83% growth. Zhejiang Orient Gene Biotech had revenue of 287.18M in the quarter ending December 31, 2025, with 68.63% growth.

• Revenue: 958.99M
• Revenue Growth: +15.83%
• P/S Ratio: 4.62
• Revenue / Employee: 421.35K
• Employees: 2,434
• Market Cap: 4.43B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	958.99M	131.08M	15.83%
Dec 31, 2024	827.92M	7.76M	0.95%
Dec 31, 2023	820.16M	-7.95B	-90.65%
Dec 31, 2022	8.77B	-1.40B	-13.78%
Dec 31, 2021	10.17B	6.90B	211.43%